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Survival of a cohort of women 
with cervical cancer diagnosed 
in a Brazilian cancer center
Sobrevida de mulheres com câncer 
de colo uterino diagnosticadas em 
um centro brasileiro
ABSTRACT
OBJECTIVE: To assess overall survival of women with cervical cancer and 
describe prognostic factors associated.
METHODS: A total of 3,341 cases of invasive cervical cancer diagnosed at 
the Brazilian Cancer Institute, Rio de Janeiro, southeastern Brazil, between 
1999 and 2004 were selected. Clinical and pathological characteristics and 
follow-up data were collected. There were performed a survival analysis using 
Kaplan-Meier curves and a multivariate analysis through Cox model.
RESULTS: Of all cases analyzed, 68.3% had locally advanced disease at the 
time of diagnosis. The 5-year overall survival was 48%. After multivariate 
analysis, tumor staging at diagnosis was the single variable signifi cantly 
associated with prognosis (p<0.001). There was seen a dose-response 
relationship between mortality and clinical staging, ranging from 27.8 to 749.6 
per 1,000 cases-year in women stage I and IV, respectively.
CONCLUSIONS: The study showed that early detection through prevention 
programs is crucial to increase cervical cancer survival.
DESCRIPTORS: Uterine Cervical Neoplasms. Early Detection of Cancer. 
Delayed Diagnosis. Survival Analysis.
Artigos Originais
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Cervical cancer is one of the most common cancers 
worldwide, the sixth in incidence and the third leading 
cause of death among women .16 Most cases (80%) 
are reported in developing countries in Africa, Latin 
America and the Caribbean, and they are relatively 
uncommon in Europe, Israel and the US.a In Brazil, 
cervical cancer is the second leading cause of death due 
to cancer in women. The Brazilian Ministry of Health 
estimated approximately 18,430new cases in 2010b with 
4,315 deaths confi rmed in 2008.c
The major prognostic factor of cervical cancer is tumor 
staging. Tumor staging according to the International 
Federation of Gynecology and Obstetrics11 (FIGO) 
staging system is directly associated with risk of recur-
rence and overall survival. It assesses the primary tumor 
size, local extension, invasion of adjacent structures, 
and presence of distant lesions. However, the FIGO 
staging system does not assess several other factors 
such as age, skin color, socioeconomic condition and 
histopathological type of tumor, which have also been 
reported as prognostic factors.7,d
RESUMO
OBJETIVO: Avaliar a sobrevida global de mulheres com câncer de colo uterino 
e identifi car fatores prognósticos relacionados.
MÉTODOS: Todos os 3.341 casos tratados no Instituto Nacional de Câncer, 
Rio de Janeiro, RJ, entre 1999 e 2004 foram selecionados e seus dados clínicos, 
anatomo-patológicos e de seguimento foram coletados. Foram utilizados a 
curva de Kaplan-Meier e o modelo de Cox para avaliação da sobrevida e para 
análise logística múltipla, respectivamente.
RESULTADOS: Dos casos estudados, 68,3% apresentavam doença localmente 
avançada. A sobrevida global em cinco anos foi de 48%. Após análise múltipla, 
o estádio clínico ao diagnóstico foi a única variável signifi cativamente associada 
com o prognóstico (p < 0,001). Mortalidade e o estádio clínico da doença 
apresentaram efeito dose-resposta, variando de 27,8 por 1.000 casos-ano a 
749,6 por 1.000 casos-ano em mulheres com estádio I e IV, respectivamente. 
CONCLUSÕES: Os resultados mostram que a detecção precoce por meio de 
programas de prevenção é fundamental para aumentar a sobrevida em câncer 
cervical.
DESCRITORES: Neoplasias do Colo do Útero. Detecção Precoce de 
Câncer. Diagnóstico Tardio. Análise de Sobrevida.
INTRODUCTION
a Ferlay J, Parkin DM, Pisani P. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: International Agency for 
Research on Cancer; 2004.
b Ministério da Saúde, Secretaria Nacional de Assistência a Saúde, Instituto Nacional de Câncer. Estimativa da incidência e mortalidade por 
câncer no Brasil. Rio de Janeiro; 2007.
c Ministério da Saúde. DATASUS. 1. Sistema de Informação de Mortalidade (SIM). Indicadores e Dados Básicos - Brasil - 2008. IDB-2008. 
Brasília; 2009.
d American Joint Committee on Cancer. Manual for staging of cancer: cervix uteri. 3. ed. Philadelphia: Lippincott; 1998.
e International Agency for Research on Cancer. IARC confi rms effi cacy of cervix cancer screening for women 25-65 in reducing mortality. 
Lyon; 2004. [cited 2011 Mar 15]Available from: http://www.iarc.fr/en/media-centre/pr/2004/pr151.html
f Ministério da Saúde. DATASUS. 1. Sistema de Informação de Mortalidade (SIM). Indicadores e Dados Básicos - Brasil - 2005. IDB-2005. 
Brasília; 2006. [cited 2011 Mar 15] Available from: http://tabnet.datasus.gov.br/cgi/idb2005/matriz.htm
There is a clear relationship between the extension 
of disease at diagnosis (tumor staging) and disease-
associated mortality. This is the basis for screening 
programs,10 which can effectively detect pre-invasive or 
early stage disease and thus reduce associated morbidity 
and mortality.1,11,e
The present study aimed at analyzing overall survival of 
women diagnosed with cervical cancer and describing 
prognostic factors associated.
METHODS
The Brazilian National Cancer Institute (Instituto 
Nacional do Câncer  – INCA) is a reference center for 
cancer prevention and control in Brazil. The INCA 
serves both the metropolitan area of the city of Rio de 
Janeiro and the rest of the state. In 2003, of 896 cases of 
cervical cancer diagnosed in the city of Rio de Janeiro, 
and 2010 cases in the state,f 597 patients were attended 
at the center.
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A retrospective study with data obtained from INCA 
registries was conducted. All cases of primary cervical 
tumors diagnosed from 1999 to 2004 were assessed. 
Since 1999 the Hospital do Câncer 2 (HC2), one of 
the four INCA units, is a reference center for all gyne-
cologic cancer cases.
The following variables were analyzed: age; tumor 
staging; histopathological type of tumor; level of 
education; skin color; and year of diagnosis.
Age was divided into two groups: <65 years and ≥65 
years. Level of education was categorized as 11 or more 
years of schooling and less than 11 years of schooling. 
Skin color was categorized as white and non-white.
Cases were classifi ed according to the FIGO staging 
system, stages I to IV. Histopathologically tumors were 
classifi ed as: squamous cell carcinoma; adenocarci-
noma; and other types.
The chi-square test was used to assess the association 
between tumor staging and the independent variables.
For estimating survival, all deaths during the study 
period were considered events; the remaining cases 
were censored at the last hospital visit on November 
2006. Data on deaths were collected from the hospital 
registry and the Brazilian Mortality Database (SIM). 
Kaplan-Meier curves were used to analyze overall 
survival and the log-rank test was used for comparing 
survival curves.
The association between survival (dependent variable) 
and independent variables (staging, histopathological 
type of tumor, age, skin color, level of education and 
year of diagnosis) was assessed through Cox propor-
tional hazards model. The proportional hazard assump-
tion was assessed by visual inspection of the log minus 
log plot proportional hazards test. The case-fatality rate 
at each stage was calculated based on the number of 
deaths per person-time (incidence density).
The study was approved by INCA Ethics Commitee on 
Research (Process nº 52/2006).
RESULTS
A total of 3,341 patients with primary cervical tumors 
were attended at INCA during the study period, of 
which 68 were excluded due to missing information. 
The maximum follow-up time was 94.0 months 
(median 28.1 months).
Most patients at early stage (I) were treated with surgery 
as single therapy (69.5%) followed by local radiation 
therapy (22.5%). Only 18% of these patients were 
treated with radiation therapy only. This standard of 
care did not change along the period analyzed.
Patients with locally advanced disease (FIGO stages II 
and III) were treated with radiation therapy (69.8%). 
Combined radiation therapy and chemotherapy (weekly 
cisplatin) was used in 21% and it is important to note 
that beginning in 2004 this standard of care changed 
(78.5% received combined treatment).
Table 1 shows case distribution according to clinical 
and epidemiological characteristics by stage. Overall, 
missing data were minimal (age in one patient, skin 
color in 2, and level of education in 4 patients). Most 
Table 1. Clinical and epidemiological characteristics of cervical cancer cases according to stages. Rio de Janeiro, Southeastern 
Brazil, 1999–2004. (N = 3,341)
Variable
Total
Tumor staging p-value
I II III IV
n % n % n % n % n % X2
Age (years)
<65 2,817 81.9 842 89.4 905 79.9 950 78.1 120 80.5
<0.001≥65 623 18.1 100 10.6 228 20.1 266 21.9 29 19.5
Skin color
White 1,909 55.5 535 56.9 647 57.1 644 53.0 83 55.7
0.168
Non-white 1,530 44.5 406 43.1 486 42.9 572 47.0 66 44.3
Schooling (years)
<11 3,114 90.6 811 86.3 1012 89.4 1154 94.9 137 91.9
<0.001≥11 323 9.4 129 13.7 120 10.6 62 5.1 12 8.1
Histological type of tumor
Squamous cell carcinoma 2,908 84.5 757 80.4 944 83.3 1084 89.1 123 82.6
<0.001Adenocarcinoma 414 12.0 146 15.5 146 12.9 102 8.4 20 13.4
Adenosquamous and others 119 3.5 39 4.1 43 3.8 31 2.5 6 4.0
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patients were white, <65 years of age, and poorly 
educated. The most prevalent histological type of 
tumor was squamous cell carcinoma (84.5%). Locally 
advanced disease (stages II and III) was seen in 68.3% 
of the cohort. Most cases were followed-up for at least 
two years (80.7%), and 1,499 deaths were recorded 
(50.1% of cases). Deaths occurred more often in the 
fi rst two years of follow-up (71.2%) and at stages II or 
III (84.9% of all deaths).
The chi-square analysis showed that the number of 
patients with 11 years of schooling or more was signifi -
cantly greater at stages I and II (p<0.001), although they 
accounted for a small proportion of the cohort. Despite 
slight predominance of white patients, no statistically 
signifi cant difference was seen in the distribution of 
cases by stage (p=0.168). Squamous cell carcinoma 
was most commonly seen at FIGO stage III while 
adenocarcinoma and adenosquamous carcinoma (plus 
other histological types) were more often seen at early 
stages (p<0.001). Year of diagnosis was not statistically 
signifi cant (p=0.144) in this analysis.
Figures 1 and 2 show the Kaplan-Meier curves. The 
median survival for the entire cohort was 53.4 months 
(95% CI 47.65;59.20) and the 5-year overall survival 
was 48%. A signifi cant difference was found in median 
survival between the two age groups studied (62.6 vs. 
41.3 months, higher in the younger age group; p=0.016; 
Fig. 1.A). Although not signifi cant, non-white women 
showed better survival compared with white ones 
(56.43 vs. 49.46 months; p=0.04; Fig. 1.B). As for 
level of education (Fig. 1.C), those with 11 years of 
schooling or more showed a signifi cantly better survival 
(median survival has not yet been estimated for this 
subgroup). The median survival for those with lower 
education was 49.9 months, p<0.001. The histological 
type of tumor (Fig. 1.D) was not statistically different 
in terms of survival as survival curves were very similar 
(p=0.09). There was a clear relationship between tumor 
staging at diagnosis and survival (Fig. 2), i.e., greater 
survival rates were found at stage I (no median survival 
estimated), and progressively reduced at more advanced 
stages (65.6 months, 21.7 months and 10.4 months for 
stages II, III and IV, respectively; p<0.001).
In the multiple logistic analysis using Cox model 
only tumor staging remained statistically signifi cant 
(p<0.001) (Table 2) while all other variables from the 
univariate analysis lost their statistical signifi cance.
The case-fatality rate in Table 3 showed a dose-response 
effect between mortality and clinical stage, ranging 
from 27.8 to 749.6 per 1,000 cases-year in women at 
stages I and IV, respectively.
Table 2. Cox models for mortality of the cohort of women 
with invasive cervical cancer. Rio de Janeiro, Southeastern 
Brazil, 1999–2004.
Characteristics
Univariate
Multiple 
logistic analysis
Cox model Cox model 1
HR p-value HRadj p-value
Age (years)
<65 1 1
≥65 1.17 0.016 0.95 0.399
Skin color
White 1 1
Non-white 1.11 0.040 1.09 0.107
Schooling (years)
<11 1 1
≥11 0.65 <0.001 0.86 0.172
Hystological type of 
tumor
0.012 0.881
Squamous cell 
carcinoma
1 1
Adenocarcinoma 0.79 0.004 0.96 0.637
Adenosquamous 
and others
0.87 0.354 0.97 0.836
Tumor staging <0.001 <0.001
Stage I 1 1
Stage II 4.90 <0.001 4.90 <0.001
Stage III 11.44 <0.001 11.33 <0.001
Stage IV 28.96 <0.001 28.91
Year of diagnosis 0.995 0.778 0.998 0.927
Table 3. Case-fatality rate adjusted for tumor staging in women with invasive cervical cancer. Rio de Janeiro, Southeastern 
Brazil, 1999–2004.
Staging Deaths Case-year
Case-fatality rate (95% CI) Median time
(1000 case-year) (years)
I 90 3,232.5 27.8 (22.6;34.2) -
II 469 3,444.5 136.2 (124.4;149.1) 5.4
III 803 2,518.2 318.9 (297.6;341.7) 1.8
IV 137 182.8 749.6 (634.0;886.2) 0.9
Total 1,499 9,377.8 159.8 (151.9;168.1) 4.5
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DISCUSSION
There are few Brazilian studies on survival of women 
with cervical cancer. A reference center in Paraná, 
southern Brazil, reported 2,396 cases (1990–1994) with 
a 5-year survival of 53.6%.gAnother study conducted 
in São Paulo, southeastern Brazil, reported an overall 
5-year survival of 66.5% representing a unexpectedly 
high survival rate (66.5%) for advanced cases.2
According to the American Cancer Society, the 5-year 
overall survival in the US is 72%.h Population-based 
studies have reported cancer survival rates of 62.5% in 
the  United Kingdomi14 and 58% in Australia.1
This scenario is signifi cantly worst in less developed 
regions. Although data from the 1980s in Cuba showed 
g Liga Paranaense de Combate ao Câncer. Relatório Epidemiológico: RHC 2000 a 2004. Curitiba: Hospital Erasto Gaertner; 2007.
h American Cancer Society. Cancer facts and fi gures. Atlanta; 1999.
i London Research Institute. Cancer Research United Kingdom. Cancer Statistics in the United Kingdom. London; 2009. [cited Mar 19]
Available from: http://info.cancerresearchuk.org/cancerstats/types/cervix/survival
*Log-rank estimated by the Mantel-Cox test.
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Figure 1. Kaplan-Meier survival curves for women with invasive cervical cancer according to age, skin color/ethnicity, level of 
education and histological type of tumor. Rio de Janeiro, Southeastern Brazil, 1999–2004. 
666 Survival in a cohort of women with cervical cancer Carmo CC & Luiz RR
a 53.5% 5-year overall survival, lower rates have been 
reported in some cities in Asia: 46.5% in Bombay, 
India; 37.5% in Qidong, China; and 24.6% in Rizal, 
Philippines.1
Low socioeconomic condition has been associated with 
poor prognosis in cervical cancer.5,7,9 In our study level 
of education was a proxy of socioeconomic condition 
and there were two major fi ndings: more educated 
women were a small minority (9.4%) of the cohort 
studied and they had a 35% reduction in the risk of death 
when compared with those less educated. However, this 
difference fell a non-signifi cant 14% in the multiple 
logistic analysis. This association may be explained by 
the fact that more educated women usually seek health 
care and have more knowledge on prevention and thus 
their disease is detected at an earlier phase with more 
successful treatment. However, in the multiple logistic 
analysis, the clinical magnitude of the difference 
between level of education (HR 0.86) remained after 
adjustment, despite losing its statistical signifi cance.
Data from hospital registries in Japan have showed 
that older age is associated with a poorer cancer 
survival, even after adjusting for tumor stage, and 
this fi nding is also associated with more effective 
screening at younger ages (<45 years).9 Another study 
has argued there are adverse biological factors that 
may cause a more aggressive course.11 However, the 
North American Surveillance, Epidemiology and End 
Results Program (SEER) did not fi nd any signifi cant 
difference after adjusting for other causes of death and 
life expectancy when assessing case-fatality rate due to 
cervical cancer in different age groups.8 In the present 
study, although advanced age was also associated with a 
poorer prognosis (HR = 1.17) in the univariate analysis, 
this association disappeared in the multiple logistic 
analysis. The high prevalence of locally advanced 
cancer at advanced ages may have contributed to a 
poorer survival in the univariate analysis.
A trend towards a worse prognosis has been reported 
for the histological types adenocarcinoma and adenos-
quamous carcinoma compared with squamous cell 
carcinoma,3,11 although this same trend was not seen in 
the multiple logistic analysis in our study. One plau-
sible explanation may be the small number of patients 
with adenocarcinoma and adenosquamous carcinoma 
subtypes, which were most commonly seen at early 
stages. Another factor possibly associated is the use 
of more aggressive treatments in these cases (adjuvant 
radiation therapy), which may have contributed to 
increased survival. However, this is not completely 
understood, and the presence of residual confounding 
cannot be ruled out.
According to the SEER,3 white women are diagnosed 
at earlier stages and have a more favorable prognosis 
when compared with black ones (HR = 1.35). This 
is mainly attributed to unequal access to health care 
and different treatment provided.4,6 In our cohort, in 
the multiple logistic analysis there was no signifi cant 
survival difference between white and non-white 
women. Given the greater number of white compared 
with non-white patients, it should be emphasized that, 
according to the 2003 National Household Survey 
*Log-rank<0.001
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Figure 2. Kaplan-Meier survival curves for women with invasive cervical cancer according to tumor staging. Rio de Janeiro, 
Southeastern Brazil, 1999–2004.
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(PNAD),j white women accounted for 61.4% of the 
population in the state of Rio de Janeiro, which may 
partially explain this difference.
Early screening and tumor staging were the main prog-
nostic factors in the population studied. Although age 
and level of education had an effect in the univariate 
analysis, it disappeared in the multiple analysis, sugges-
ting an independent effect of staging. This fi nding is 
consistent with the literature and confi rms tumor staging 
as the main prognostic factor in cervical cancer.11 The 
prognostic signifi cance of staging becomes more evident 
when the case-fatality rate at each stage is estimated.
The study limitations are related to the retrospective 
design and use of secondary data with no further details 
on treatment, such as delayed or prolonged radiation 
therapy and surgical procedures. Selection bias is unli-
kely to have affected the results because most women 
in the cohort were followed up for at least two years. 
Lead-time bias was not likely as approximately 70% 
of the cases were locally advanced.
This study is probably not representative of the 
national reality of cervical cancer given that there 
are wide socioeconomic differences among Brazilian 
macroregions (especially the North and Northeast 
regions).[8] However, the results of our study are repre-
sentative of the metropolitan area of Rio de Janeiro and, 
to a lesser extent, of the Southeast region. The 48% 
5-year overall survival, compared with more developed 
countries like the US (72%),1 indicates a less favorable 
outcome consistent with that of developing countries.1
The low overall survival found at the INCA may be 
attributed to delayed combined treatment (radiation 
therapy plus chemotherapy, the standard care for locally 
advanced disease). With poorer prognosis at more 
advanced stages, it is remarkable the disproportionate 
high number of cases with locally advanced stages (85%, 
51% and 24% at stages I, II and III, respectively), slightly 
lower rates than those reported in the US and UK.2,4
Further studies with longer follow-up are needed to 
explore improvement in specifi c-stage survival benefi t 
with the recent introduction of chemotherapy plus radia-
tion therapy as the standard care for locally advanced 
cancer. There is also a need for mass campaigns and 
prevention programs for adequate cancer management 
so to achieve a plateau in overall survival similar to that 
seen in developed countries.
j Instituto Brasileiro de Geografi a e Estatística. Pesquisa Nacional por Amostra de Domicílios 2003. Rio de Janeiro; 2003 [cited 2011 Apr 9]. 
Available from: http://www.ibge.gov.br/home/estatistica/populacao/trabalhoerendimento/pnad2008/ default.shtm
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